(EMAILWIRE.COM, October 17, 2017 ) The Europe Prostate Cancer Market was worth $13.92 billion in 2016 and estimated to be growing at a CAGR of 9.1%, to reach $21.52 billion by 2021. Market access restrictions to high-cost agents for prostate cancer are increasingly influential in European markets.
Prostate...more
(EMAILWIRE.COM, October 17, 2017 ) A Vaccine adjuvant is a component of a vaccine that supports to create a stronger immune response in the patient’s body. Specifically, adjuvants help vaccines work better. Some vaccines prepared from deteriorated or dead germs comprise of naturally occurring Vaccine...more
(EMAILWIRE.COM, October 17, 2017 ) The Europe Cold Chain Market was worth USD 61.97 billion in 2016 and is expected to be growing at a CAGR of 7.2%, to touch USD 87.74 billion by 2021. Cold Chains is the term used for temperature controlled supply chains. The uses of Cold Chains involve the preserving...more
(EMAILWIRE.COM, October 17, 2017 ) The market is showing evident potential in the mentioned forecast period. Increasing research and development activities on monoclonal antibodies is expected to drive sales of Protein A resins in the future.
Monoclonal antibodies can be defined as an antibody...more
(EMAILWIRE.COM, October 17, 2017 ) The Europe Liquid Biopsy market is expected to increase at a CAGR of 21.45% in the forecast period of 2016-2021 and reach a value of USD 358.69 million by 2021 from USD 135.75 million in 2016. Europe region is also showing high growth in liquid biopsy industry in...more
(EMAILWIRE.COM, October 17, 2017 ) The Middle East and Africa Stem Cell Assay Market was worth USD 43.3 Million in 2016 and is estimated to be growing at a CAGR of 16.3%, to reach USD 92.24 Million by 2021. Stem cells acquired from human embryo have the potential to grow into any type of cell in...more
(EMAILWIRE.COM, October 17, 2017 ) The Middle East and Africa Alcohol Ingredients Market was worth USD 0.10 billion in 2016 and expected to be growing at a CAGR of 8.13%, to reach USD 0.14 billion by 2021.
Alcohol ingredients such as yeast, flavours & salts, enzymes, colours and other ingredients...more
(EMAILWIRE.COM, October 17, 2017 ) An excipient is a natural or synthetic constituent formulated alongside the active ingredient of a medication, included for the purpose of inducing and catalysing a wide range of physical and chemical properties.
The Europe market for Pharmaceutical Excipients...more
(EMAILWIRE.COM, October 17, 2017 ) The Global Radioimmunoassay Market was worth USD 369 million in 2016 and estimated to be growing at a CAGR of 3.52%, to reach USD 438.68 million by 2021. Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens...more
(EMAILWIRE.COM, October 17, 2017 ) The Europe Cervical Cancer Diagnostics and Therapeutics market has been estimated at USD 955.80 Million in 2016 and is projected to reach USD 1129.72 Million by 2021, at a CAGR of 3.40% during the forecast period from 2016 to 2021. Cervical cancers and cervical...more
(EMAILWIRE.COM, October 17, 2017 ) The Middle East and Africa pre-harvest market was estimated to be worth around USD 3.92 billion in 2016 and is expected to reach USD 5.13 billion by 2021, growing at the CAGR of 5.52% from 2016 to 2021. Farm operations are timely performed and the quality of agricultural...more
(EMAILWIRE.COM, October 17, 2017 ) Fluid management is a critical part of every diagnostic and angiographic procedure. It minimizes the programming and installation costs. Entire workflow of fluid management system is automated, safe, digitized and online. The credit of the rising interest on the...more
(EMAILWIRE.COM, October 17, 2017 ) The Latin America Thrombectomy Devices Market was worth USD 120 million in 2016 and estimated to be growing at a CAGR of 6.93%, to reach USD 160 million by 2021. Thrombectomy Devices can be defined as removal of thrombi by use of surgical procedures in cases of...more
(EMAILWIRE.COM, October 17, 2017 ) The Europe Biopsy Devices Market was worth $449.5 million in 2016 and estimated to be growing at a CAGR of 7.1%, to reach $633.4 million by 2021. Europe holds the second major market for biopsy device Market owing to acceptance of advanced technology in biotechnology...more
(EMAILWIRE.COM, October 17, 2017 ) The Europe NGS market which was worth $0.96 billion by the end of 2016 is expected to reach $2.33 billion by 2021 at a CAGR of 19.3%.The Next Generation Sequencing market is categorized by product (software and services) and by applications. By product it is segmented...more